The Role of Delafloxacin in Patients with Community-Acquired Bacterial Pneumonia in the Outpatient Setting: A Budget Impact Model
ConclusionThe results of the budget impact analyses provide conservative estimates of the impact of adding delafloxacin to outpatient formularies in substitution of moxifloxacin.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
More News: Antibiotic Therapy | Asthma | Avelox | Bacterial Pneumonia | Chronic Obstructive Pulmonary | Clinical Trials | Drugs & Pharmacology | Moxifloxacin | Pneumonia | Study